22 May 2013
Keywords: accolate, approved, young, children, usa, astrazeneca, leukotriene
Article | 23 September 1999
AstraZeneca's leukotriene D4 inhibitor Accolate (zafirlukast) hasbeen approved in the USA for the treatment of asthma in children aged over ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.